Medtronic (MDT) Stock Forecast & Price Target

$91.12 -2.10 (-2.25%)

Closing price 08/21/2025 03:59 PM Eastern

Extended Trading

$91.25 +0.13 (+0.14%)

As of 08/21/2025 07:52 PM Eastern

Medtronic - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
0

Hold
8

Buy
11

Based on 19 Wall Street analysts who have issued ratings for Medtronic in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 8 have given a hold rating, 9 have given a buy rating, and 2 have given a strong buy rating for MDT.

Consensus Price Target

$101.15
11.01% Upside

According to the 19 analysts' twelve-month price targets for Medtronic, the average price target is $101.15. The highest price target for MDT is $110.00, while the lowest price target for MDT is $95.00. The average price target represents a forecasted upside of 11.01% from the current price of $91.12.

Get the Latest News and Ratings for MDT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Medtronic and its competitors.

MDT Analyst Ratings Over Time

Type	Current Forecast 8/22/24 to 8/22/25	1 Month Ago 7/23/24 to 7/23/25	3 Months Ago 5/24/24 to 5/24/25	1 Year Ago 8/23/23 to 8/22/24
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	9 Buy rating(s)	9 Buy rating(s)	7 Buy rating(s)	4 Buy rating(s)
Hold	8 Hold rating(s)	11 Hold rating(s)	8 Hold rating(s)	9 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$101.15	$98.19	$96.07	$92.54
Forecasted Upside	11.01% Upside	6.69% Upside	19.04% Upside	5.32% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Hold	Hold

MDT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MDT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Medtronic Stock vs. The Competition

Type	Medtronic	Medical Companies	S&P 500
Consensus Rating Score	2.68	2.79	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	11.01% Upside	12,764.22% Upside	11.95% Upside
News Sentiment Rating	Positive News See Recent MDT News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/21/2025	Citigroup 2 of 5 stars	Joanne Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$99.00 ➝ $101.00	+9.69%
8/21/2025	Truist Financial 3 of 5 stars	Richard Newitter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Hold ➝ Hold	$92.00 ➝ $96.00	+4.50%
8/20/2025	UBS Group 3 of 5 stars	Danielle Antalffy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$94.00 ➝ $95.00	+1.83%
8/20/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$98.00 ➝ $100.00	+7.19%
8/20/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lee Hambright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$97.00 ➝ $98.00	+8.99%
8/20/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Rescott Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$94.00 ➝ $96.00	+6.77%
8/14/2025	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
7/16/2025	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$98.00 ➝ $100.00	+12.04%
7/15/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Cecilia Furlong Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$98.00 ➝ $107.00	+20.16%
7/11/2025	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral ➝ Neutral
Get the Latest News and Ratings for MDT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.
7/11/2025	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Vazquez Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
7/8/2025	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vijay Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$103.00 ➝ $106.00	+20.83%
6/30/2025	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Peer Perform
6/16/2025	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Kratky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/16/2025	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Kratky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$110.00	+26.16%
5/22/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shagun Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$105.00 ➝ $101.00	+24.10%
11/26/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$105.00 ➝ $109.00	+27.11%
11/15/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$99.00 ➝ $96.00	+9.84%
8/23/2024	Daiwa America Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Department Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/21/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$85.00 ➝ $90.00	+4.41%
8/21/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$85.00 ➝ $87.00	+1.90%
8/21/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$92.00 ➝ $94.00	+10.10%
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sell	$83.00	+1.84%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:19 AM ET.

Should I Buy Medtronic Stock? MDT Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, August 19, 2025. Please send any questions or comments about these Medtronic pros and cons to contact@marketbeat.com.

Medtronic
Bull Case

Here are some ways that investors could benefit from investing in Medtronic plc:

Medtronic plc recently reported strong quarterly earnings, with earnings per share exceeding analysts' expectations, indicating robust financial performance.
The current stock price is around $92.74, reflecting a stable market position and potential for growth.
The company has a solid dividend yield of 3.1%, which can provide a steady income stream for investors.
Medtronic plc has a healthy balance sheet, evidenced by a quick ratio of 1.42 and a current ratio of 1.85, suggesting good short-term financial health.
Analysts have a consensus rating of "Moderate Buy" for the stock, with a target price indicating potential upside from the current levels.

Medtronic
Bear Case

Investors should be bearish about investing in Medtronic plc for these reasons:

The company has a relatively high dividend payout ratio of 78.45%, which may limit its ability to reinvest in growth opportunities.
Recent analyst reports have shown mixed ratings, with some firms downgrading their outlook, indicating uncertainty in future performance.
Medtronic plc's stock has experienced fluctuations, with a 52-week high of $96.25 and a low of $79.29, suggesting volatility that could deter risk-averse investors.
The company's debt-to-equity ratio of 0.53, while manageable, indicates some reliance on debt financing, which could pose risks in a rising interest rate environment.
Market conditions and competition in the medical technology sector may impact Medtronic plc's growth prospects, leading to potential challenges ahead.

MDT Forecast - Frequently Asked Questions

: According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Medtronic is $101.15, with a high forecast of $110.00 and a low forecast of $95.00.
: 19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 8 hold ratings, 9 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MDT shares.
: According to analysts, Medtronic's stock has a predicted upside of 11.01% based on their 12-month stock forecasts.
: Over the previous 90 days, Medtronic's stock had 3 upgrades by analysts.
: Medtronic has been rated by research analysts at BTIG Research, Citigroup, Evercore ISI, Leerink Partners, Leerink Partnrs, Mizuho, Morgan Stanley, Needham & Company LLC, Robert W. Baird, Sanford C. Bernstein, Truist Financial, UBS Group, Wells Fargo & Company, William Blair, and Wolfe Research in the past 90 days.
: Analysts like Medtronic less than other "medical" companies. The consensus rating score for Medtronic is 2.68 while the average consensus rating score for "medical" companies is 2.79. Learn more on how MDT compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:MDT) was last updated on 8/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medtronic (MDT) Stock Forecast & Price Target